Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06124131 · ClinicalTrials.gov registry record · NA
Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening
A NA study, sponsored by Tulane University.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT06124131 is a NA study that has completed, run by Tulane University. The registered enrollment target is 50 participants.
The verdict
NCT06124131, a NA study, has completed, sponsored by Tulane University.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The goal of this pilot clinical trial is to determine feasibility and explore whether financial incentives paid to primary care patients for completing colorectal cancer screening increase completion of colorectal cancer screening. The main questions it aims to answer are: * Do patient financial incentives for completing colorectal cancer screening increase screening completion? * Does a patient financial incentive for colorectal cancer screening offered alongside patient financial incentives for COVID-19 and flu shots increase completion of those shots? Participants who are due for colorectal cancer screening will receive telephone outreach from primary care staff who will offer a stool-based colorectal cancer screening. Participants will be randomly assigned to either Group 1 or Group 2. Group 1 participants will be offered financial incentives for completing COVID-19 and flu shots within 2 months of enrollment. Group 2 participants will be offered financial incentives for completing a COVID-19 shot, a flu shot, and colorectal cancer screening within 2 months of enrollment. Researchers will compare to see if completion of a COVID-19 shot, a flu shot, and colorectal cancer screening is different between the two groups.
Interventions
- BEHAVIORAL Financial incentive for colorectal cancer screening
- BEHAVIORAL Financial incentive for flu shot
- BEHAVIORAL Financial incentive for COVID-19 shot
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-11-11 |
| Est. Completion | 2024-03-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06124131
The ClinicalTrials.gov registry entry for NCT06124131 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tulane University, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Financial incentive for colorectal cancer screening is the first listed.
NCT06124131 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06124131 about?
NCT06124131 is a clinical study titled "Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening". The goal of this pilot clinical trial is to determine feasibility and explore whether financial incentives paid to primary care patients for completing colorectal cancer screening increase completion of colorectal cancer screening. The main questions it aims to answer are: * Do patient financial in...
What is the current status of trial NCT06124131?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2023-11-11. Estimated completion is 2024-03-25.
What interventions are being tested in trial NCT06124131?
The interventions under investigation include: Financial incentive for colorectal cancer screening (BEHAVIORAL), Financial incentive for flu shot (BEHAVIORAL), Financial incentive for COVID-19 shot (BEHAVIORAL).
Who is sponsoring clinical trial NCT06124131?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.